Alteration of Myocardial Deformations in Diabetes: Relationship to Micro-angiopathy

Not Applicable

Completed

• Conditions: Diabetes Mellitus, Type 1
• Interventions: Device: Echocardiographic 2D strain analysis

• Registration Number: NCT01220349
• Lead Sponsor: University Hospital, Bordeaux

Brief Summary

Despite careful monitoring of patients with diabetes, it is so far difficult to predict the occurrence of cardiac events in the evolution. As shown by various studies conducted in patients with diabetes, cardiac involvement can be detected by abnormalities of diastolic or systolic functions using non-invasive investigations such as echocardiography. For 4 years, the evaluation technique of myocardial deformations by two-dimensional speckle tracking strain by echocardiography is the subject of high hopes in the earlier detection of still asymptomatic cardiomyopathies. In the present study, the investigators hypothesized that this technique would improve the detection of myocardial contraction abnormalities in patients with insulin-dependent diabetes mellitus (IDDM), and would establish their association with micro-angiopathy, frequently encountered in these patients.

Detailed Description

This is a single center case-control study based on routine care, designed to recruit patients with type 1 diabetes mellitus free from any other myocardiopathy. The inclusion will take place over a period of 24 months. No monitoring of patients (no follow-up) is provided under this protocol. The analysis will focus on the combination of the left ventricle myocardial deformations alteration revealed by the echocardiographic 2D strain analysis (\< 18% in absolute value), with the existence of micro-angiopathy in type 1 diabetes mellitus patients with preserved left ventricular ejection fraction ( ≥ 60%).

Two hundred subjects with type 1 diabetes mellitus will be recruited: 100 subjects with impaired left ventricular myocardial deformation by 2D strain analysis (\< 18% in absolute value), constituting the 'cases' group and 100 subjects without alteration in myocardial deformation (global strain ≥ 18%).

Study Timeline

• Study First Submitted: 2010-10-07
• Study First Submitted QC: 2010-10-11
• Study First Posted: 2010-10-13
• Study Start: 2011-01
• Primary Completion: 2012-10
• Study Completion: 2012-10
• Status Verified: 2013-04
• Last Update Submitted: 2013-04-18
• Last Update Posted: 2013-04-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 61

Inclusion Criteria

• aged between 18 and 45 years
• with diagnosed Type 1 diabetes mellitus (with or without complications or peripheric vascular micro-angiopathy)
• having a negative myocardial ischemic test (exercise echocardiography) in the previous month inclusion

Exclusion Criteria

• Known or suspected coronary artery disease
• atrial fibrillation
• hypertension
• moderate to severe valvular disease
• sequelae of myocardial infarction
• secondary or primary cardiomyopathy
• myocardial conduction abnormalities
• pregnancy or breastfeeding.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Echocardiographic 2D strain analysis	Echocardiographic 2D strain analysis	-

Primary Outcome Measures

Name	Time	Method
Measurement of the alteration of left ventricular myocardial strain (≤ 18% in absolute value) by echocardiography and the relationship to micro-angiopathy.	Inclusion : Day 1

Secondary Outcome Measures

Name	Time	Method
Analyses of this association (alteration of myocardial strain and micro-angiopathy) in relation with the duration of diabetes, and other co-factors such as dyslipidemia, unstable diabetes, and coexisting macro-angiopathy.	Inclusion : Day 1

Trial Locations

Locations (1)

Hôpital Cardiologique du Haut-Lévêque, Service de Cardiologie et Maladies Vasculaires; 🇫🇷 Pessac, France